Cargando…

A strategy of vascular‐targeted therapy for liver fibrosis

BACKGROUND AND AIMS: No effective treatments are available for liver fibrosis. Angiogenesis is deeply involved in liver fibrogenesis. However, current controversial results suggest it is difficult to treat liver fibrosis through vascular targeting. There are three different microvessels in liver: po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yuan, Dong, Meng‐Qi, Liu, Zhi‐Min, Xu, Meng, Huang, Zhi‐Hao, Liu, Hong‐Juan, Gao, Yi, Zhou, Wei‐Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543235/ https://www.ncbi.nlm.nih.gov/pubmed/34940991 http://dx.doi.org/10.1002/hep.32299

Ejemplares similares

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
por: Qi, Si-Min, et al.
Publicado: (2021)

Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies
por: Dong, Qingfu, et al.
Publicado: (2023)

Comparison on different traditional Chinese medicine therapies for chronic hepatitis B liver fibrosis
por: Dai, Yun-kai, et al.
Publicado: (2022)

Novel strategy of combined interstitial macrophage depletion with intravenous targeted therapy to ameliorate pulmonary fibrosis
por: Li, Zhongxian, et al.
Publicado: (2023)

Dihydroergotamine ameliorates liver fibrosis by targeting transforming growth factor β type II receptor
por: Zheng, Ke-Xin, et al.
Publicado: (2023)

A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy
por: Wang, Zhi-Qi, et al.
Publicado: (2015)

Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy
por: Tan, Zui, et al.
Publicado: (2021)

miR-4739 mediates pleural fibrosis by targeting bone morphogenetic protein 7
por: Wang, Meng, et al.
Publicado: (2019)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

Targeting NAD+: is it a common strategy to delay heart aging?
por: Yuan, Yang, et al.
Publicado: (2022)

Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges
por: Yu, De-Hua, et al.
Publicado: (2020)

Effects of aspirin and enoxaparin in a rat model of liver fibrosis
por: Li, Chen-Jie, et al.
Publicado: (2017)

Advances in ultrasound-targeted microbubble-mediated gene therapy for liver fibrosis
por: Huang, Cuiyuan, et al.
Publicado: (2017)

Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis
por: Zhang, Ya-Wen, et al.
Publicado: (2021)

Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives
por: Nan, Yang, et al.
Publicado: (2022)

Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis
por: Dai, Yun-Kai, et al.
Publicado: (2022)

Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis
por: Zhao, Xue-Ke, et al.
Publicado: (2017)

Clinical Advancements in the Targeted Therapies against Liver Fibrosis
por: Bansal, Ruchi, et al.
Publicado: (2016)

Regression of liver fibrosis: evidence and challenges
por: Sun, Ya-Meng, et al.
Publicado: (2020)

Novel Therapeutic Targets in Liver Fibrosis
por: Zhang, Jinhang, et al.
Publicado: (2021)

The Role of Butylidenephthalide in Targeting the Microenvironment Which Contributes to Liver Fibrosis Amelioration
por: Chuang, Hong-Meng, et al.
Publicado: (2016)

Liver-Targeting and pH-Sensitive Sulfated Hyaluronic Acid Mixed Micelles for Hepatoma Therapy
por: Li, Zhi-peng, et al.
Publicado: (2019)

Clinical cure and liver fibrosis reversal after postoperative antiviral combination therapy in hepatitis B-associated non-cirrhotic hepatocellular carcinoma: A case report
por: Yu, Xue-Ping, et al.
Publicado: (2021)

Efficacy and Treatment Strategies in Advanced Cancers with Liver Metastasis Receiving Atezolizumab Therapy
por: Yin, Wen-Jing, et al.
Publicado: (2021)

Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis
por: Bu, Fang-tian, et al.
Publicado: (2022)

Targeted changes in blood lipids improves fibrosis in renal allografts
por: Zhang, Yang-He, et al.
Publicado: (2023)

Putative endothelial progenitor cells do not promote vascular repair but attenuate pericyte–myofibroblast transition in UUO-induced renal fibrosis
por: Yang, Juan, et al.
Publicado: (2019)

Plasma biomarker screening for liver fibrosis with the N-terminal isotope tagging strategy
por: Li, ShuLong, et al.
Publicado: (2011)

Sodium(+)/taurocholate cotransporting polypeptide as target therapy for liver fibrosis
por: Salhab, Ahmad, et al.
Publicado: (2022)

Transient Elastography and Ultrasonography: Optimal Evaluation of Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease
por: Zhang, Geng-lin, et al.
Publicado: (2019)

Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients
por: Liu, Yupeng, et al.
Publicado: (2022)

Cellular senescence primes liver fibrosis regression through Notch‐EZH2
por: Song, Ping, et al.
Publicado: (2023)

MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization
por: Zhang, Jie, et al.
Publicado: (2022)

Fuzhenghuayu Decoction ameliorates hepatic fibrosis by attenuating experimental sinusoidal capillarization and liver angiogenesis
por: Liu, Hong-liang, et al.
Publicado: (2019)

Current ultrasound-related strategies for assessing liver fibrosis in chronic liver disease
por: Xue, Li-Yun, et al.
Publicado: (2020)

Engineering nanotheranostic strategies for liver cancer
por: Cao, Lei, et al.
Publicado: (2021)

New strategy for monitoring targeted therapy: molecular imaging
por: Teng, Fei-Fei, et al.
Publicado: (2013)

Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis
por: Liu, Peng, et al.
Publicado: (2023)

Promising Therapy Candidates for Liver Fibrosis
por: Wang, Ping, et al.
Publicado: (2016)

Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
por: Chen, Zhijin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_60bc1chhh5if5o450elao577jc